Tools to identify the men with prostate cancer most appropriate for active surveillance?

por Getzenberg, Robert H
Publicado 2014

How do we define “castration” in men on androgen deprivation therapy?

por Itty, Sarin, Getzenberg, Robert H
Publicado 2020

Hormone levels following surgical and medical castration: defining optimal androgen suppression

por Schweizer, Michael T, Hancock, Michael L, Getzenberg, Robert H, Yu, Evan Y
Publicado 2018

Prostate cancer-derived angiogenin stimulates the invasion of prostate fibroblasts

por Jones, Michelle L, Ewing, Charles M, Isaacsa, William B, Getzenberg, Robert H
Publicado 2012

Cancer/Testis antigens as potential predictors of biochemical recurrence of prostate cancer following radical prostatectomy

por Shiraishi, Takumi, Terada, Naoki, Zeng, Yu, Suyama, Takahito, Luo, Jun, Trock, Bruce, Kulkarni, Prakash, Getzenberg, Robert H
Publicado 2011

Preliminary evaluation of urinary soluble Met as a Biomarker for urothelial carcinoma of the bladder

por McNeil, Brian K, Sorbellini, Maximiliano, Grubb, Robert L, Apolo, Andrea, Cecchi, Fabiola, Athauda, Gagani, Cohen, Benjamin, Giubellino, Alessio, Simpson, Haley, Agarwal, Piyush K, Coleman, Jonathan, Getzenberg, Robert H, Netto, George J, Shih, Joanna, Linehan, W Marston, Pinto, Peter A, Bottaro, Donald P
Publicado 2014